Evidence map›Paper›PMID 22305042›Full record

ReviewJournal of the American Academy of Dermatology2012

An overview of clinical and experimental treatment modalities for port wine stains.

Jennifer K Chen, Pedram Ghasri, Guillermo Aguilar, Anne Margreet van Drooge, Albert Wolkerstorfer, Kristen M Kelly, Michal Heger

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Journal of the American Academy of Dermatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 57 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05771311 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Potassium Tetanyl Phosphate Laser vs Pulsed Dye Laser for Treating Port-Wine Stains - A Prospective, Split-Side Study

TypeinterventionalSponsorUniversitätsklinikum Hamburg-EppendorfRan2023 to 2023Enrolled30ConditionsPort-Wine StainArmsKTP, PDL
NCT07183644 narecruitingnot on this mapstarted 2026, after this paper: background citation

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

TypeinterventionalSponsorUniversity of Texas Southwestern Medical CenterRan2026 to 2028Enrolled200ConditionsPort Wine StainsArmsPulse Dye laser, Pulse Dye Laser (PDL) pulse width stacking, Pulse Dye Laser (PDL) followed by Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet laser) laser., IPL (Intense Pulsed Light) followed by Pulse Dye Laser (PDL), Cupping followed by Pulse Dye Laser (PDL)
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Laser and light-based treatments for port-wine birthmarks - a systematic review and network meta-analysis.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Noninvasive Diagnosis Revealed a Strong Therapeutic Response and Skin Barrier Changes in Hemoporfin-Mediated Photodynamic Therapy for Port-Wine Stains.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Photo-Mediated Ultrasound Therapy (PUT) for the Treatment of Deep Cutaneous Vasculature.IEEE open journal of ultrasonics, ferroelectrics, and frequency control · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jennifer K ChenBeckman Laser Institute and Medical Clinic, University of California, Irvine, California, USA.
Pedram Ghasri
Guillermo Aguilar
Anne Margreet van Drooge
Albert Wolkerstorfer
Kristen M Kelly
Michal Heger

Funding

Novel Optical Treatment Approach for Vascular BirthmarksR01HD065536 · NICHD · UNIVERSITY OF CALIFORNIA-IRVINE · PI CHOI, BERNARD, KELLY, KRISTEN M · 2010 to 2014
$1.4M
Port wine stain treatment for infants and young childrenK01HD042057 · NICHD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI AGUILAR, GUILLERMO · 2002 to 2006
$577k
Photodynamic and Photothermal Port Wine Stain TreatmentR03AR051443 · NIAMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI KELLY, KRISTEN M · 2004 to 2006
$226k
NIAMS NIH HHS AR51443NIAMS NIH HHS R03 AR051443NICHD NIH HHS HD042057NICHD NIH HHS HD065536NICHD NIH HHS K01 HD042057NICHD NIH HHS R01 HD065536
6 · The paper itself

Abstract

Port wine stains (PWS) are the most common vascular malformation of the skin, occurring in 0.3% to 0.5% of the population. Noninvasive laser irradiation with flashlamp-pumped pulsed dye lasers (selective photothermolysis) currently comprises the gold standard treatment of PWS; however, the majority of PWS fail to clear completely after selective photothermolysis. In this review, the clinically used PWS treatment modalities (pulsed dye lasers, alexandrite lasers, neodymium:yttrium-aluminum-garnet lasers, and intense pulsed light) and techniques (combination approaches, multiple passes, and epidermal cooling) are discussed. Retrospective analysis of clinical studies published between 1990 and 2011 was performed to determine therapeutic efficacies for each clinically used modality/technique. In addition, factors that have resulted in the high degree of therapeutic recalcitrance are identified, and emerging experimental treatment strategies are addressed, including the use of photodynamic therapy, immunomodulators, angiogenesis inhibitors, hypobaric pressure, and site-specific pharmaco-laser therapy.

Indexed as

Angiogenesis InhibitorsHumansImmunosuppressive AgentsLow-Level Light TherapyPort-Wine StainAngiogenesis InhibitorsImmunosuppressive Agents

Identifiers

PMID22305042
PMCPMC4143189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.